Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Hep C Discussion Forum -> Hep C News -> European Medicines Agency Validates Gilead's Marketing Application for Ledipasvir/Sofosbuvir
Post Info TOPIC: European Medicines Agency Validates Gilead's Marketing Application for Ledipasvir/Sofosbuvir
Matt Chris


Guru

Status: Offline
Posts: 1782
Date:
RE: European Medicines Agency Validates Gilead's Marketing Application for Ledipasvir/Sofosbuvir
Permalink  
 

Hey Wayne

Yes I read this article its very likely that it will be approved because their is nothing better.

What I would like to see is the FDA or some other US government agency do is Negotiate a price for these over $100.00 per pill drugs like the Individual countries do around the world.

 Why should Egypt and India, China and other some countries with the same standard of living or higher pay hundreds of dollars less than the US. It just shows how the government has again failed its people.

matt 



__________________

"And in the end, the love you take is equal to the love you make"

61 year old Geno type A1, F4 Cirrhotic, started 24 weeks on Harvoni 12-17-14 ,EOT-5 week = UND, 8-31-15 =UND , SVR-24 Baby YES! 
Tig


Admin

Status: Offline
Posts: 9281
Date:
Permalink  
 

In light of the US Congressional investigation into Gilead's price structure for Sovaldi, it will be interesting to follow the considerations made by Gilead in the EU and the expectations of the EU members. There should be reasonable demands placed on them after they shocked the world with Sovaldi.  Obviously if nothing is done to reconsider the intial price offering to retail sources, we're sure to see a considerable increase in per dose costs. I don't think anyone outside of the Gilead organization saw the $1000/pill price of Sovaldi coming. I would require them to release such information and make a good faith effort to meet a fair release price of their sure to be popular single pill combo. If wishes were fishes, we'd all be swimming... 

Tig



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 
OldenSlow


Senior Member

Status: Offline
Posts: 380
Date:
Permalink  
 

"...Although accelerated assessment of this investigational fixed-dose combination could shorten EMA's review time by approximately two months, it does not guarantee a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) or final approval by the European Commission. If approved, LDV/SOF could be available for marketing in the EU by the end of 2014."

http://hcvadvocate.blogspot.com/2014/03/european-medicines-agency-validates.html

 

 



-- Edited by OldenSlow on Friday 28th of March 2014 03:47:30 AM

__________________

66 y/o male - Geno 1b - F4 cirrhotic dx 2001 - 16 wk treatment w/ Sovaldi/Olysio/Riba - Und @ EOT+24 SVR

 
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.
Hep C Discussion Forum -> Hep C News -> European Medicines Agency Validates Gilead's Marketing Application for Ledipasvir/Sofosbuvir
Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.